Connection

DANIEL MUSHER to Pneumococcal Infections

This is a "connection" page, showing publications DANIEL MUSHER has written about Pneumococcal Infections.
Connection Strength

5.661
  1. The Ongoing Genetic Adaptation of Streptococcus pneumoniae. J Clin Microbiol. 2017 03; 55(3):681-685.
    View in: PubMed
    Score: 0.463
  2. Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant. Hum Vaccin Immunother. 2016; 12(2):331-5.
    View in: PubMed
    Score: 0.434
  3. Genetic Control of Antibody Responses to Pneumococcal Capsular Polysaccharides. Clin Infect Dis. 2016 Jan 01; 62(1):132-3.
    View in: PubMed
    Score: 0.425
  4. How effective is vaccination in preventing pneumococcal disease? Infect Dis Clin North Am. 2013 Mar; 27(1):229-41.
    View in: PubMed
    Score: 0.356
  5. Editorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults? Clin Infect Dis. 2012 Jul; 55(2):265-7.
    View in: PubMed
    Score: 0.335
  6. The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence? Clin Infect Dis. 2011 Mar 01; 52(5):633-40.
    View in: PubMed
    Score: 0.310
  7. Sinusitis complicated by dural sinus thrombosis and Streptococcus pneumoniae endocarditis: a case report and review of the literature. J Infect. 2007 Aug; 55(2):106-10.
    View in: PubMed
    Score: 0.237
  8. Pneumococcal vaccine--direct and indirect ("herd") effects. N Engl J Med. 2006 Apr 06; 354(14):1522-4.
    View in: PubMed
    Score: 0.221
  9. Pneumococcal serotypes and virulence. J Infect Dis. 2006 Feb 01; 193(3):477; author reply 477-8.
    View in: PubMed
    Score: 0.218
  10. Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J Infect Dis. 2005 Apr 01; 191(7):1063-7.
    View in: PubMed
    Score: 0.205
  11. Sinusitis. N Engl J Med. 2005 Jan 13; 352(2):203-4; author reply 203-4.
    View in: PubMed
    Score: 0.203
  12. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. Arch Intern Med. 2001 Nov 26; 161(21):2538-44.
    View in: PubMed
    Score: 0.163
  13. Protection against bacteremic pneumococcal infection by antibody to pneumolysin. J Infect Dis. 2001 Mar 01; 183(5):827-30.
    View in: PubMed
    Score: 0.154
  14. Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Infect Dis. 2001 Jan 15; 32(2):307-10.
    View in: PubMed
    Score: 0.153
  15. Genetic control of the immunologic response to pneumococcal capsular polysaccharides. Vaccine. 2000 Nov 08; 19(6):623-7.
    View in: PubMed
    Score: 0.152
  16. A brief history of the pneumococcus in biomedical research. Semin Respir Infect. 1999 Sep; 14(3):198-208.
    View in: PubMed
    Score: 0.140
  17. Pneumococcal outbreaks in nursing homes. N Engl J Med. 1998 Jun 25; 338(26):1915-6.
    View in: PubMed
    Score: 0.129
  18. Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia. Ann Am Thorac Soc. 2015 Oct; 12(10):1482-9.
    View in: PubMed
    Score: 0.107
  19. Spinal and paraspinal pneumococcal infections-a review. Eur J Clin Microbiol Infect Dis. 2014 Apr; 33(4):517-27.
    View in: PubMed
    Score: 0.095
  20. Pneumococcal vaccination for patients with spinal cord injury. Arch Phys Med Rehabil. 1993 Dec; 74(12):1354-7.
    View in: PubMed
    Score: 0.094
  21. Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin Infect Dis. 1993 Jul; 17(1):66-73.
    View in: PubMed
    Score: 0.091
  22. Pneumococcal pyomyositis: report of 2 cases and review of the literature. Clin Infect Dis. 2012 Aug; 55(3):e12-7.
    View in: PubMed
    Score: 0.084
  23. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis. 1992 Apr; 14(4):801-7.
    View in: PubMed
    Score: 0.084
  24. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect Immun. 1990 Dec; 58(12):3871-6.
    View in: PubMed
    Score: 0.076
  25. The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century. Medicine (Baltimore). 2010 Sep; 89(5):331-336.
    View in: PubMed
    Score: 0.075
  26. Pneumococcal vaccination: work to date and future prospects. Am J Med Sci. 1990 Jul; 300(1):45-52.
    View in: PubMed
    Score: 0.074
  27. Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection? J Infect Dis. 1990 Apr; 161(4):736-40.
    View in: PubMed
    Score: 0.073
  28. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. J Infect Dis. 2010 Feb 15; 201(4):516-24.
    View in: PubMed
    Score: 0.072
  29. Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia. J Infect Dis. 2000 Jul; 182(1):158-67.
    View in: PubMed
    Score: 0.037
  30. Genetic relatedness among nontypeable pneumococci implicated in sporadic cases of conjunctivitis. J Clin Microbiol. 1999 Dec; 37(12):4039-41.
    View in: PubMed
    Score: 0.036
  31. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999 Jan; 18(1):1-9.
    View in: PubMed
    Score: 0.033
  32. Confusion and knee pain after a car accident. Hosp Pract (1995). 1998 Sep 15; 33(9):144, 147.
    View in: PubMed
    Score: 0.033
  33. BOX-polymerase chain reaction-based DNA analysis of nonserotypeable Streptococcus pneumoniae implicated in outbreaks of conjunctivitis. J Infect Dis. 1997 Nov; 176(5):1401-5.
    View in: PubMed
    Score: 0.031
  34. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis. 1996 Jun; 173(6):1347-53.
    View in: PubMed
    Score: 0.028
  35. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis. 1996 Jan; 22(1):100-6.
    View in: PubMed
    Score: 0.027
  36. Pneumococcal virulence factors and host immune responses to them. Eur J Clin Microbiol Infect Dis. 1995 Jun; 14(6):479-90.
    View in: PubMed
    Score: 0.026
  37. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother. 1995 May; 39(5):1166-8.
    View in: PubMed
    Score: 0.026
  38. Pneumococcal vaccine after 15 years of use. Another view. Arch Intern Med. 1994 Nov 28; 154(22):2531-5.
    View in: PubMed
    Score: 0.025
  39. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med. 1994 Sep 08; 331(10):643-8.
    View in: PubMed
    Score: 0.025
  40. A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin Infect Dis. 1993 Nov; 17(5):913-24.
    View in: PubMed
    Score: 0.023
  41. Unusual manifestations of pneumococcal infection in human immunodeficiency virus-infected individuals: the past revisited. Clin Infect Dis. 1992 Jan; 14(1):192-9.
    View in: PubMed
    Score: 0.021
  42. The effect of Listeria monocytogenes on resistance to pneumococcal infection. Proc Soc Exp Biol Med. 1970 Nov; 135(2):557-60.
    View in: PubMed
    Score: 0.019
  43. Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. Infect Immun. 1990 Sep; 58(9):3135-8.
    View in: PubMed
    Score: 0.019
  44. Analysis of mutations in the pbp genes of penicillin-non-susceptible pneumococci from Turkey. Clin Microbiol Infect. 2006 Feb; 12(2):150-5.
    View in: PubMed
    Score: 0.014
  45. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis. 1996 Jan; 173(1):83-90.
    View in: PubMed
    Score: 0.007
  46. In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin. Antimicrob Agents Chemother. 1995 Dec; 39(12):2798-800.
    View in: PubMed
    Score: 0.007
  47. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis. 1992 Mar; 165(3):553-6.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.